UK markets closed

Amicus Therapeutics, Inc. (0HF9.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
9.38-0.91 (-8.84%)
At close: 06:39PM BST
Full screen
Previous close10.29
Open9.50
Bid0.00 x N/A
Ask0.00 x N/A
Day's range9.28 - 9.52
52-week range9.28 - 14.57
Volume1,473
Avg. volume814
Market cap27.496M
Beta (5Y monthly)0.79
PE ratio (TTM)N/A
EPS (TTM)-0.97
Earnings date09 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates

    Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 66.67% and 1.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates

    1Q 2024 Total Revenue of $110.4M, a 28% Increase Year-over-Year Guiding to Full-Year 2024 Total Revenue Growth of 25%-30% at CER Raising Full-Year 2024 Galafold® Guidance on Continued Strong Demand Strong Pombiliti® + Opfolda® Launch with Increasing Rate of Commercial Patient Starts Reiterating Full-Year Non-GAAP Profitability Projected in 2024 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicat

  • GlobeNewswire

    Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference

    PRINCETON, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T. A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations. About Amicus Therapeutics Amicus Therapeutics (